Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.

Du ZP, Wu BL, Xie YM, Zhang YL, Liao LD, Zhou F, Xie JJ, Zeng FM, Xu XE, Fang WK, Li EM, Xu LY.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2240-50. doi: 10.1016/j.bbamcr.2015.07.007. Epub 2015 Jul 17.

2.

Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.

Kobara H, Miyamoto T, Suzuki A, Asaka R, Yamada Y, Ishikawa K, Kikuchi N, Ohira S, Shiozawa T.

Placenta. 2013 Nov;34(11):1036-43. doi: 10.1016/j.placenta.2013.08.004. Epub 2013 Aug 20.

PMID:
23972287
3.

Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma.

Wu B, Li C, Du Z, Yao Q, Wu J, Feng L, Zhang P, Li S, Xu L, Li E.

Sci Rep. 2014 Jun 23;4:5403. doi: 10.1038/srep05403.

4.

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.

Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25.

PMID:
25728945
5.

Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.

Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, Zhang X, Niu Y, Shen Z, Shen J, Wu X, Li E.

J Clin Pathol. 2007 May;60(5):555-61. Epub 2007 Apr 5.

6.

Cell Signaling Pathway in 12-O-Tetradecanoylphorbol-13-acetate-Induced LCN2 Gene Transcription in Esophageal Squamous Cell Carcinoma.

Meng L, Wang M, Du Z, Fang Z, Wu B, Wu J, Xie W, Shen J, Zhu T, Xu X, Liao L, Xu L, Li E, Lan B.

Biomed Res Int. 2017;2017:9592501. doi: 10.1155/2017/9592501. Epub 2017 Oct 2.

7.

Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.

Chung IH, Chen CY, Lin YH, Chi HC, Huang YH, Tai PJ, Liao CJ, Tsai CY, Lin SL, Wu MH, Chen CY, Lin KH.

Oncotarget. 2015 Jun 20;6(17):15050-64.

8.

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.

PMID:
23696034
9.

HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.

Koh SA, Lee KH.

Oncol Rep. 2015 Oct;34(4):2179-87. doi: 10.3892/or.2015.4189. Epub 2015 Aug 10.

PMID:
26259977
10.

Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G.

J Mol Med (Berl). 2009 Aug;87(8):803-13. doi: 10.1007/s00109-009-0486-8. Epub 2009 May 23.

11.

Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.

Wu CH, Ko JL, Chen SC, Lin YW, Han CP, Yang TY, Chien MH, Wang PH.

Gynecol Oncol. 2014 Feb;132(2):474-82. doi: 10.1016/j.ygyno.2013.11.032. Epub 2013 Dec 4.

PMID:
24316309
12.

Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells.

Chung TW, Choi HJ, Kim CH, Jeong HS, Ha KT.

Biochim Biophys Acta. 2013 Dec;1833(12):3386-3395. doi: 10.1016/j.bbamcr.2013.10.011. Epub 2013 Oct 19.

13.

Lipocalin 2 promotes breast cancer progression.

Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3913-8. doi: 10.1073/pnas.0810617106. Epub 2009 Feb 23.

14.

Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells.

Wang X, Lu N, Niu B, Chen X, Xie J, Cheng N.

Mol Cancer Res. 2012 May;10(5):588-96. doi: 10.1158/1541-7786.MCR-11-0416. Epub 2012 Apr 20.

15.

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

Tung MC, Hsieh SC, Yang SF, Cheng CW, Tsai RT, Wang SC, Huang MH, Hsieh YH.

Prostate. 2013 Sep;73(12):1281-90. doi: 10.1002/pros.22670. Epub 2013 Jun 15.

PMID:
23775308
16.

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.

Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB.

Cancer Res. 2009 Nov 15;69(22):8579-84. doi: 10.1158/0008-5472.CAN-09-1934. Epub 2009 Nov 3.

17.

Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways.

Chien MH, Ying TH, Yang SF, Yu JK, Hsu CW, Hsieh SC, Hsieh YH.

Cell Biochem Biophys. 2012 Dec;64(3):177-86. doi: 10.1007/s12013-012-9370-1.

PMID:
22707293
18.

Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.

Lee EK, Kim HJ, Lee KJ, Lee HJ, Lee JS, Kim DG, Hong SW, Yoon Y, Kim JS.

Int J Oncol. 2011 Feb;38(2):325-33. doi: 10.3892/ijo.2010.854. Epub 2010 Dec 3.

PMID:
21132267
19.

Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.

Mir SU, Jin L, Craven RJ.

J Biol Chem. 2012 Apr 27;287(18):14494-501. doi: 10.1074/jbc.M111.324921. Epub 2012 Mar 14.

20.

Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.

Gaudineau B, Fougère M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S.

J Cell Sci. 2012 Oct 1;125(Pt 19):4475-86. doi: 10.1242/jcs.099879. Epub 2012 Jul 5.

Supplemental Content

Support Center